首页 | 本学科首页   官方微博 | 高级检索  
     


Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment
Authors:Esa Jarkko Mikael Kari  Milla Elvi Linnea Kuusisto  Päivi Honkavaara  Anna Hakalahti  Kirsi-Maria Haapasaari  Risto Bloigu  Peeter Karihtala  Hanna-Riikka Teppo  Risto Pirinen  Taina Turpeenniemi-Hujanen  Outi Kuittinen
Affiliation:1. Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland;2. Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland;3. Medical Informatics and Statistics Research Group, University of Oulu, Oulu, Finland;4. Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland

Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland;5. Department of Pathology, North Karelia Central Hospital, Joensuu, Finland;6. Department of Oncology, Faculty of Health Medicine, Institute of Clinical Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland

Abstract:
Keywords:diffuse large B-cell lymphoma  doxorubicin  etoposide  R-CHOEP  thioredoxin-1
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号